The effect of Dopaflex and Viregyt-K on gait and postural disturbances of operated and non-operated Parkinsonian patients

Clinical Trial

G Boczán et al. Ther Hung. 1975.

. 1975;23(1):17-20.

No abstract available

Similar articles

[The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
Shiozawa R, Kase M, Kuroiwa Y, Narabayashi H, Nishitani Y, Ohmoto T, Toyokura Y, Uono K. Shiozawa R, et al. No To Shinkei. 1981 Mar;33(3):301-9. No To Shinkei. 1981. PMID: 7018522 Clinical Trial. Japanese. No abstract available.
Clinical and electromyographic examinations on the effect of hydrochloride (Viregyt-K) in the treatment of Parkinson's disease.
Schubert U, Fischer GJ, Glass J. Schubert U, et al. Ther Hung. 1977;25(2):55-63. Ther Hung. 1977. PMID: 898119 No abstract available.
The effect of dopaflex on the clinical picture and reaction time of parkinsonian patients.
Antal J. Antal J. Ther Hung. 1974;22(2):70-8. Ther Hung. 1974. PMID: 4419534 No abstract available.
Twenty-five years of amantadine therapy in Parkinson's disease.
Danielczyk W. Danielczyk W. J Neural Transm Suppl. 1995;46:399-405. J Neural Transm Suppl. 1995. PMID: 8821075 Review.
Levodopa unresponsive symptoms in Parkinson disease.
Sethi K. Sethi K. Mov Disord. 2008;23 Suppl 3:S521-33. doi: 10.1002/mds.22049. Mov Disord. 2008. PMID: 18781679 Review.